Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated review

New insights into the organization and regulation of the apical polarity network in mammalian epithelial cells

(2021) Eleanor Martin et al.   FEBS Journal

SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis

(2021) Armin Bayati et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint

(2021) Taruneet Kaur et al.   VIRUS RESEARCH

Group I p21-activated kinases in leukemia cell adhesion to fibronectin

(2021) Kateřina Kuželová et al.   Cell Adhesion & Migration

SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site

(2021) Anna Z Mykytyn et al.   eLife

Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19

(2021) Dingzhong Li et al.   Topics in Current Chemistry

Par‐3 family proteins in cell polarity & adhesion

(2021) Barry J. Thompson   FEBS Journal

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2

(2021) Yinghui Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

(2021) Kui K. Chan et al.   Science Advances

Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury

(2021) Murat Oz et al.   BIOMEDICINE & PHARMACOTHERAPY

Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity

(2021) Maryam Eskandari Mehrabadi et al.   BIOMEDICINE & PHARMACOTHERAPY

A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2

(2021) Jayanta Kumar Das et al.   GENOME

Coronavirus infection: An immunologists' perspective

(2021) Juan Bautista De Sanctis et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation

(2021) Zsuzsanna Miklós et al.   Cells

Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies

(2021) Min Li et al.   ADVANCED MATERIALS

Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals

(2021) Abdou Nagy et al.   ARCHIVES OF VIROLOGY

Progress in the therapeutic inhibition of Cdc42 signalling

(2021) Natasha P. Murphy et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection

(2021) Babajan Banaganapalli et al.   COMPUTERS IN BIOLOGY AND MEDICINE

Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach

(2021) Motiur Rahaman et al.   COMPUTERS IN BIOLOGY AND MEDICINE

In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR

(2021) María Asunción Barreda-Manso et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The lethal internal face of the coronaviruses: Kidney tropism of the SARS , MERS , and COVID 19 viruses

(2021) Roza Motavalli et al.   IUBMB LIFE

Nanotherapeutics for treating coronavirus diseases

(2021) Thennakoon M. Sampath U. Gunathilake et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

(2021) Lennox Chitsike et al.   Virology Journal

Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity

(2021) Mackenzie E. Coden et al.   Viruses-Basel

Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19

(2021) Pradeep Singh Cheema et al.   Open Biology

Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS‐CoV‐2

(2021) Hua Zhu et al.   Advanced Science

The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?

(2021) Annamaria Vianello et al.   Biomedicines

Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection

(2021) Thomas L. Williams et al.   Communications Biology

Pulmonary Aerosolized Formulation or Nasal Drops containing Recombinant Human Angiotensin converting Enzyme 2 (rhACE2) as a Potential Therapy against COVID-19

(2021) Amjad Ayoub et al.   Research Journal of Pharmacy and Technology

Cell entry by SARS-CoV-2

(2021) Ruchao Peng et al.   TRENDS IN BIOCHEMICAL SCIENCES

Compounds with therapeutic potential against novel respiratory 2019 coronavirus

(2020) Miguel Angel Martinez   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases

(2020) Tawar Qaradakhi et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors

(2020) Kengo Azushima et al.   CURRENT HYPERTENSION REPORTS

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

(2020) Haibo Zhang et al.   INTENSIVE CARE MEDICINE

circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway

(2020) Yinjie Su et al.   Molecular Cancer

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Coronavirus puts drug repurposing on the fast track

(2020) Charlotte Harrison   NATURE BIOTECHNOLOGY

First Case of 2019 Novel Coronavirus in the United States

(2020) Michelle L. Holshue et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

(2020) Daniel Wrapp et al.   SCIENCE

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

(2020) Michael Letko et al.   Nature Microbiology

An update on ACE2 amplification and its therapeutic potential

(2020) Alonso Marquez et al.   Acta Physiologica

Extracellular vesicles as drug delivery systems: Why and how?

(2020) Omnia M. Elsharkasy et al.   ADVANCED DRUG DELIVERY REVIEWS

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

(2020) B. Coutard et al.   ANTIVIRAL RESEARCH

Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

(2020) Furong Qi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Plasma microRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy

(2020) Jazmin Marquez-Pedroza et al.   BIOSCIENCE REPORTS

A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance

(2020) Krishna Sriram et al.   BRITISH JOURNAL OF PHARMACOLOGY

Non-coding RNA therapeutics for cardiac regeneration

(2020) Luca Braga et al.   CARDIOVASCULAR RESEARCH

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

(2020) Carly G.K. Ziegler et al.   CELL

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

(2020) Vanessa Monteil et al.   CELL

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

COVID-19: a new challenge for human beings

(2020) Penghui Yang et al.   Cellular & Molecular Immunology

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

(2020) Wanbo Tai et al.   Cellular & Molecular Immunology

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

(2020) Mahmoud Gheblawi et al.   CIRCULATION RESEARCH

Mesenchymal Stem Cell–Derived Extracellular Vesicles Alleviate Acute Lung Injury Via Transfer of miR-27a-3p

(2020) Jiangmei Wang et al.   CRITICAL CARE MEDICINE

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

(2020) Paolo Verdecchia et al.   European Journal of Internal Medicine

Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis

(2020) Xiu-wu Pan et al.   INTENSIVE CARE MEDICINE

Novel Coronavirus COVID-19

(2020) Christopher Vannabouathong et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Human neutralizing antibodies elicited by SARS-CoV-2 infection

(2020) Bin Ju et al.   NATURE

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

(2020) Jun Lan et al.   NATURE

The proximal origin of SARS-CoV-2

(2020) Kristian G. Andersen et al.   NATURE MEDICINE

RNA delivery by extracellular vesicles in mammalian cells and its applications

(2020) Killian O’Brien et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

(2020) Muthiah Vaduganathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA-27a-3p aggravates renal ischemia/reperfusion injury by promoting oxidative stress via targeting growth factor receptor-bound protein 2

(2020) X.-R. Zhao et al.   PHARMACOLOGICAL RESEARCH

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

(2020) Shutoku Matsuyama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?

(2020) Li Xiao et al.   Viruses-Basel

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2020) Xiuyuan Ou et al.   Nature Communications

Antihypertensive drugs and risk of COVID-19? – Authors' reply

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

(2020) Cynthia Liu et al.   ACS Central Science

CD40L Reverse Signaling Influences Dendrite Spine Morphology and Expression of PSD-95 and Rho Small GTPases

(2020) Paulina Carriba et al.   Frontiers in Cell and Developmental Biology

Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies

(2020) Georgia Ragia et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting

(2020) Ali Hosseini Rad SM et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study

(2020) Ismail Celı̇k et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)

(2020) Owen Wiese et al.   JOURNAL OF CLINICAL PATHOLOGY

Broad and differential animal ACE2 receptor usage by SARS-CoV-2

(2020) Xuesen Zhao et al.   JOURNAL OF VIROLOGY

The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients

(2020) Nutpakal Ketprasit et al.   MALARIA JOURNAL

Extrapulmonary manifestations of COVID-19

(2020) Aakriti Gupta et al.   NATURE MEDICINE

Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2

(2020) Stepan Nersisyan et al.   PLoS One

ACE2 and COVID-19 and the resulting ARDS

(2020) Xiaoqing Zhang et al.   POSTGRADUATE MEDICAL JOURNAL

COVID-19: A promising cure for the global panic

(2020) Balachandar Vellingiri et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2

(2020) Alex Renn et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy

(2020) Mina K. Chung et al.   EBioMedicine

Discovery and characterization of ACE2 – a 20-year journey of surprises from vasopeptidase to COVID-19

(2020) Nigel M. Hooper et al.   CLINICAL SCIENCE

An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2

(2020) Abhijit Sarma et al.   COMPUTATIONAL BIOLOGY AND CHEMISTRY

COVID-19 update: The race to therapeutic development

(2020) Julianne D. Twomey et al.   DRUG RESISTANCE UPDATES

COVID-19: fighting the invisible enemy with microRNAs

(2020) Neeraj Chauhan et al.   Expert Review of Anti-Infective Therapy

ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases

(2020) Ravindra K. Sharma et al.   HYPERTENSION

T cell responses and therapies against SARS‐CoV‐2 infection

(2020) Salman M. Toor et al.   IMMUNOLOGY

Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics

(2020) Arafat Rahman Oany et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

(2020) Simin Seyedpour et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The ACE2 as a “rescue protein” or “suspect enzyme” in COVID-19: possible application of the “engineered inactive hrsACE2” as a safer therapeutic agent in the treatment of SARS-CoV-2 infection

(2020) Reza Khodarahmi et al.   Journal of the Iranian Chemical Society

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

(2020) Sukrit Narula et al.   LANCET

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

(2020) Anum Glasgow et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural and functional modelling of SARS-CoV-2 entry in animal models

(2020) Greg N. Brooke et al.   Scientific Reports

Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective

(2020) Abbas Shafiee et al.   Stem Cells Translational Medicine

Human recombinant soluble ACE2 in severe COVID-19

(2020) Alexander Zoufaly et al.   Lancet Respiratory Medicine

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives

(2020) Federica Saponaro et al.   Frontiers in Molecular Biosciences

Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis

(2020) Debasmita Mukhopadhyay et al.   Brain Sciences

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges

(2020) Hongpeng Jia et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Active and Inactive Cdc42 Differ in Their Insert Region Conformational Dynamics

(2020) Nurit Haspel et al.   BIOPHYSICAL JOURNAL

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection

(2020) Vanessa Monteil et al.   EMBO Molecular Medicine

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

(2020) Chaima Mouffouk et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Neutralizing antibodies targeting SARS-CoV-2 spike protein

(2020) Shi Xiaojie et al.   Stem Cell Research

An effective drug against COVID-19: reality or dream?

(2020) Atieh Yaghoubi et al.   Expert Review of Respiratory Medicine

ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors

(2020) Zofia Wicik et al.   Journal of Clinical Medicine

Beta- and Novel Delta-Coronaviruses Are Identified from Wild Animals in the Qinghai-Tibetan Plateau, China

(2020) Wentao Zhu et al.   VIROLOGICA SINICA

Neutralizing antibodies for the treatment of COVID-19

(2020) Shibo Jiang et al.   Nature Biomedical Engineering

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection

(2019) Susumu Hamada-Tsutsumi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Human Coronavirus: Host-Pathogen Interaction

(2019) To Sing Fung et al.   Annual Review of Microbiology

Genome-wide Integrative Analysis of Zika-Virus-Infected Neuronal Stem Cells Reveals Roles for MicroRNAs in Cell Cycle and Stemness

(2019) Jason W. Dang et al.   Cell Reports

miRDB: an online database for prediction of functional microRNA targets

(2019) Yuhao Chen et al.   NUCLEIC ACIDS RESEARCH

Endoplasmic reticulum rather than mitochondria plays a major role in the neuronal apoptosis induced by polybrominated diphenyl ether-153

(2019) Xin Li et al.   TOXICOLOGY LETTERS

MicroRNA delivery through nanoparticles

(2019) Sharon Wei Ling Lee et al.   JOURNAL OF CONTROLLED RELEASE

Breaking the convention: Sialoglycan variants, Co-receptors and Alternative Receptors for Influenza A Virus Entry

(2019) Umut Karakus et al.   JOURNAL OF VIROLOGY

New insights into apical-basal polarization in epithelia

(2019) Amalia Riga et al.   CURRENT OPINION IN CELL BIOLOGY

MicroRNA 16-5p is upregulated in calorie-restricted mice and modulates inflammatory cytokines of macrophages

(2019) Kazuki Yamada et al.   GENE

Metazoan MicroRNAs

(2018) David P. Bartel   CELL

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

(2018) Anna R. Hemnes et al.   EUROPEAN RESPIRATORY JOURNAL

Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates

(2018) Xing-Hua Xiao et al.   MOLECULES

MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart

(2018) Yanru Zhao et al.   Oncotarget

Actin blobs prefigure dendrite branching sites

(2018) Vanitha Nithianandam et al.   JOURNAL OF CELL BIOLOGY

miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy

(2018) Prashanth Nagesh et al.   Cancers

Theoretical tool bridging cell polarities with development of robust morphologies

(2018) Silas Boye Nissen et al.   eLife

miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions

(2017) Chih-Hung Chou et al.   NUCLEIC ACIDS RESEARCH

DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions

(2017) Dimitra Karagkouni et al.   NUCLEIC ACIDS RESEARCH

MERS, SARS and other coronaviruses as causes of pneumonia

(2017) Yudong Yin et al.   RESPIROLOGY

CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts

(2017) Chun-Mei Tang et al.   Scientific Reports

Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy

(2016) Saini Setua et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Cdc42: Role in Cancer Management

(2015) Muhammad Imran Qadir et al.   Chemical Biology & Drug Design

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

(2015) Jean Kaoru Millet et al.   VIRUS RESEARCH

Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation bymiR-421

(2014) Daniel W. Lambert et al.   CLINICAL SCIENCE

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

(2012) Ali M. Zaki et al.   NEW ENGLAND JOURNAL OF MEDICINE